| LINE ITEM (USD / %) | FY 2025
FILED 2025-08-31 | FY 2024
FILED 2024-08-31 | FY 2023
FILED 2023-08-31 |
|---|---|---|---|
| Revenue (Total Sales) | $69.67B | $64.90B | $64.11B |
| YoY Revenue Growth % | +7.4% | +1.2% | — |
| Gross Profit | $22.24B | $21.16B | — |
| Gross Margin % | 31.9% | 32.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $10.23B | $9.60B | $8.81B |
| Operating Margin % | 14.7% | 14.8% | 13.7% |
| Net Income (GAAP) | $7.68B | $7.26B | $6.87B |
| EBITDA (Normalized) | $10.71B | $10.01B | $11.12B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $11.47B | $9.13B | $9.52B |
| Capital Expenditures (CapEx) | $600.0M | $516.5M | $2.89B |
| Free Cash Flow (FCF) | $10.87B | $8.61B | $6.64B |
| FCF Margin % | 15.6% | 13.3% | 10.4% |
| Return on Invested Capital (ROIC %) | 22.2% | 21.7% | 12.7% |
| Cash & Short-Term Equivalents | $9.65B | $8.31B | — |
| Total Debt (Short + Long Term) | $15.14B | $14.01B | $21.28B |
| Total Stockholders' Equity | $30.87B | $29.19B | $43.64B |